Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page
- Check6 days agoChange DetectedAdded a government funding notice at the top of the page and updated site revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check13 days agoChange DetectedThe page adds a glossary toggle and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with revised capitalization, and updates the revision to v3.4.0, replacing the previous v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 on the page. This appears to be a minor version update and does not affect study content.SummaryDifference0.0%

- Check49 days agoChange DetectedExpanded list of trial locations across the United States and China (e.g., California, Colorado, Georgia, Texas, Beijing, Guangzhou, Hebei, Henan, Jiangsu, Liaoning, Shanghai, Shanxi, Sichuan, Zhejiang). Some previously listed location blocks were removed.SummaryDifference1%

- Check70 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed, updating the page's revision tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page revision label was updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.